Chang, Fang-Chia, and Mark R. Opp. Role of corticotropin-releasing hormone in stressor-induced alterations of sleep in rat. releasing hormone (CRH) mediates responses to a variety of stressors. We subjected rats to a 1-h period of an acute stressor, physical restraint, and determined the impact on subsequent sleep-wake behavior. Restraint at the beginning of the light period, but not the dark period, increased waking and reduced rapid eye movement sleep without dramatically altering slow-wave sleep (SWS). Electroencephalogram (EEG) slow-wave activity during SWS and brain temperature were increased by this manipulation. Central administration of the CRH receptor antagonist astressin blocked the increase in waking after physical restraint, but not during the period of restraint itself. Blockade of CRH receptors with astressin attenuated the restraint-induced elevation of brain temperature, but not the increase of EEG slow-wave activity during subsequent SWS. Although corticosterone increased after restraint in naive animals, it was not altered by this manipulation in rats well habituated to handling and injection procedures. These results suggest that under these conditions central CRH, but not the hypothalamic-pituitary-adrenal axis, is involved in the alterations in sleep-wake behavior and the modulation of brain temperature of rats exposed to physical restraint.
hypothalamic-pituitary-adrenal axis; electroencephalogram; neuropeptide CORTICOTROPIN-RELEASING HORMONE (CRH) is well documented as the major, although not only, mediator of behavioral, physiological, and autonomic responses to a variety of stressors. CRH, expressed in widely distributed regions of the central nervous system (CNS), mediates the hypothalamic-pituitary-adrenal (HPA) axis and central autonomic components of responses to stressors (11, 30) . Sleep is a fundamental CNS process that is regulated by complex interactions between neural and humoral systems and altered in response to a variety of stressors (for review, see Ref. 26 ). Previous reports (6, 10, 32) indicate that brief periods of exposure to physical restraint at the beginning of the dark period increase rapid eye movement sleep (REMS) in rats. This REMS enhancement is modulated by the CRH receptor antagonist ␣-helical CRH-(9-41) (␣-hCRH) (10) , suggesting a role for CRH in these responses. A new CRH receptor antagonist, astressin, is now commercially available. Astressin, cyclo (30) (31) (32) (33) [D-Phe 12 ,Nle 21, 38 ,Glu 30 ,Lys 33 ]-rat/human-CRH- , is more potent than ␣-hCRH and exhibits little if any intrinsic agonist activity (15) . Astressin effectively blocks responses to a variety of stressors, including CRH-and alcohol-induced increases in ACTH (33) , and stressor-induced alterations in gastric and colonic motor function (20) . The present study was designed to further elucidate the role of CRH in responses to physical restraint by determining the effectiveness of a different CRH receptor antagonist in modulating responses to this stressor. In addition, we (28, 29, 36) have previously shown that the impact of immune challenge on sleep-wake behavior depends on the time of day at which the challenge occurs. In this study, we extend previous observations of responses to physical restraint to include manipulations at a different circadian time: the beginning of the light period of the light-dark cycle. We now report that 1 h of physical restraint differentially affects subsequent sleep-wake behavior, electroencephalogram (EEG) slow-wave activity (SWA) during slow-wave sleep (SWS), and brain temperature (Tbr), depending when the stressor is applied. Selective CRH receptor blockade with astressin abolishes or attenuates some, but not all, responses to this stressor. Our results suggest that under the conditions of this study central CRH, but not the HPA axis, is involved in restraint-induced waking and, in part, in the stressor-induced elevation of Tbr.
METHODS

Substances
Stock solutions of astressin, (Bachem, Torrance, CA) were prepared in pyrogen-free saline (PFS). Aliquots of these stock solutions were stored at Ϫ70°C until use, when they were then brought to an appropriate injection volume. We used 2.5 g (0.7 nmol) astressin in these experiments. This dose of astressin does not alter spontaneous sleep-wake behavior during the first 6 h after intracerebroventricular (ICV) administration (7) .
Animals
Male Sprague-Dawley rats (250-300 g; Harlan, Indianapolis, IN) were anesthetized (ketamine/xylazine, 87:13, mg/kg) and injected with an analgesic [butorphanol tartrate (Torbugesic)] and a broad spectrum antibiotic [penicillin G benzathine (Bicillin)]. Depending on the particular protocol (see Experimental Protocol), surgical procedures included the implantation of EEG screw electrodes, a guide cannula directed into the lateral ventricle, and a calibrated 30-k⍀ thermistor (model no. 44008, Omega Engineering, Stamford, CT) to monitor Tbr at the surface of the cortex. All procedures have been previously described (27) . The animals were allowed to recover for 7 days before the initiation of experiments. The rats were housed in individual recording cages, with two cages in each environmentally controlled chamber (model no. 352601; Hotpack, Philadelphia, PA), and maintained at 23 Ϯ 1°C with a 12:12-h light-dark cycle (25-W incandescent bulb; ϳ200 lx at cage height). Food and water were available ad libitum. All procedures performed in these studies were approved by the local animal care and use committee in accordance with the United States Department of Agriculture Animal Welfare Act and the United States Public Health Service Policy on Humane Care and Use of Laboratory Animals.
On the second postsurgical day, the rats used in behavioral studies were connected to the recording apparatus (see Apparatus and Recording) via a flexible tether. Three days after surgery, the patency and free drainage of the ICV cannulas was assessed by administering 200 ng angiotensin II (human angiotensin II octapeptide; Peninsula Laboratories); angiotensin elicits a drinking response mediated by structures in the preoptic area (12) . For the next 4-5 days, the animals were habituated by daily handling and ICV injections of PFS timed to coincide with scheduled experimental administrations. At the end of each experimental protocol, all rats were again injected with angiotensin; only data from those rats that exhibited a positive drinking response were included in the subsequent analyses.
Apparatus and Recording
Signals from the EEG electrodes and thermistors were fed into amplifiers (models S75-01 and S71-20, respectively; Colbourn Instruments, Lehigh Valley, PA). The EEG was amplified (factor of 3,000) and analog bandpass filtered between 0.1 and 40 Hz (frequency response, Ϯ3 dB; filter frequency roll off, 12 dB/octave). Gross body movements were detected by custom-built ultrasonic detectors (Biomedical Instrumentation, University of Tennessee, Memphis, TN). These conditioned signals (EEG, Tbr), as well as those from the movement detectors, were subjected to analog-to-digital conversion with 12-bit precision at a sampling rate of 128 Hz (AT-MIO-64F5; National Instruments, Austin, TX). The digitized EEG waveform, Tbr samples, and integrated values for body movements were stored as binary computer files until subsequent analyses.
Postacquisition determination of vigilance state was done by visual scoring of 12-s epochs using custom software (Icelus; M. R. Opp) written in LabView for Windows (National Instruments) as previously described (27) . The behavior of the animal was classified as either SWS, REMS, or wakefulness, based on previously defined criteria (27) .
Experimental Protocol
Two experiments were conducted in this study. Experiment 1 was conducted to determine the effects of 1-h restraint on subsequent sleep-wake behavior. Rats used in this experiment (n ϭ 16) were divided into two subgroups: dark onset (n ϭ 8) and light onset (n ϭ 8). These rats were handled each day and habituated to injection procedures by receiving ICV injections of vehicle at the same time that experiments were scheduled to begin. This habituation period lasted 1 wk, after which 24-h baseline recordings were obtained from undisturbed animals. On the day after baseline recordings, four rats from each group were injected ICV with vehicle, and the other four rats received 2.5 g (0.7 nmol) astressin. These rats were then immediately placed individually in Plexiglas Broome-style rodent restrainers (Kent Scientific, Litchfield, CT) for 1 h. During this restraint period, the restrainer was placed in the rats' home cage, and the animals were connected via the tether to the recording system. After restraint, the rats were removed from the restrainer and placed back in their home recording cage. Recordings were made during the 1-h restraint period and for 23 h after restraint. Two days later, this protocol was repeated, but the substance injected was switched. Thus each rat was restrained only twice and served as its own control. The injection volume used for these animals was 3 l, and the injections were given over an ϳ2-min period.
In experiment 2, we determined the effects of 1-h restraint on circulating corticosterone. All animals used in this experiment were maintained under the same conditions, in the same environmental chambers as those animals used in experiment 1. Two groups of rats were used in this experiment. A group of naive rats (n ϭ 36) was composed of animals that were not subjected to any surgical procedure and not handled or otherwise habituated before experiments. The naive rats served as controls for handling and injection procedures. Habituated rats (n ϭ 72) were surgically implanted only with an ICV guide cannula. During the 1-wk postsurgical period, these rats were habituated in the same manner as the rats used in experiment 1; they were handled daily and given ICV injections of vehicle at the same time that experiments were scheduled to begin. However, they were not placed in or habituated to the restrainers before the beginning of the experiment. The experimental protocol for this experiment consisted of killing animals either before the planned period of restraint (time 0), immediately at the end of the restraint period (time 1), or 1 h after the end of restraint (time 2). Naive rats were simply placed into the restrainers and killed at the indicated times with no additional manipulation. Habituated rats were injected with either vehicle (n ϭ 36) or astressin (n ϭ 36) 15 min before restraint. This 15-min interval was designed to match the time interval between injections and the beginning of physical restraint used in experiment 1. It is the amount of time required in experiment 1 to handle, inject, and place groups of rats into the restrainer tubes and connect them to the recording system. As such, the protocol used in experiment 2 was identical to that of experiment 1. Six rats were killed at each time point (time 0, 1, and 2) for each condition (vehicle and astressin). All manipulations in this experiment were conducted twice, once at the beginning of the light period and once at the beginning of the dark period, using separate groups of rats. Trunk blood was collected into EDTA-containing tubes (Vacutainer; Becton Dickinson, Franklin Lakes, NJ), and centrifuged for 15 min at 4°C. Plasma was then aliquoted and stored at Ϫ80°C until RIA.
Corticosterone RIA
Total plasma corticosterone was measured using a commercially available RIA kit (ICN Biomedicals, Costa Mesa, CA).
Statistical Analyses
Experiment 1. All values are presented as means Ϯ SE. Repeated measures ANOVA were used to reveal differences in the duration of each vigilance state (SWS, REMS, and wakefulness), for EEG SWA during SWS, Tbr values, and sleep architecture parameters. The primary analyses were done across the 11-h recording period after physical restraint. Secondary analyses consisted of repeated measures ANOVA restricted to specific time blocks comprising the major periods of the study: the 5 h immediately after restraint (hours 2-6 of protocol clock time) and the 6-h time blocks comprising the remainder of the recording period. Secondary analyses of data obtained during the 1-h period of physical restraint were done using one-way ANOVA. In all ANOVA, the main effect (between subjects) consisted of manipulation (undisturbed, ICV vehicle with restraint, and ICV astressin with restraint). If statistically significant differences were detected, Scheffé's post hoc multiple comparisons test was used to determine which manipulation during experimental conditions deviated from values obtained from the same animals during control conditions. An ␣ level of PՅ 0.05 was taken to indicate a statistically significant departure from values obtained during control conditions. Experiment 2. Circulating corticosterone concentrations are presented as means Ϯ SD (in ng/ml). One-way ANOVA was used to reveal statistically significant differences between the values obtained in response to restraint. The main effect consisted of manipulation (naive, ICV vehicle with restraint, and ICV astressin with restraint). If statistical significance was achieved, Scheffé's post hoc multiple comparisons test was used to determine which manipulation contributed to the variance. An ␣ level of PՅ 0.05 was taken to indicate statistical significance.
RESULTS
Experiment 1
Effects of restraint during light period. Physical restraint for 1 h at the beginning of the light period altered the sleep-wake behavior of rats ( Fig. 1) . While in the restrainer tube, rats spent more time awake and less time asleep relative to values obtained from the same animals left undisturbed in their recording cages ( Fig. 1 ). Post hoc analyses indicated that the amount of time spent awake did not depend on whether the animals had been injected with vehicle or 2.5 g (0.7 nmol) astressin, i.e., this CRH receptor antagonist did not alter waking during the restraint period. Alterations in sleep-wake behavior were apparent for 5 h after the animals were removed from the restraining device. During this 5-h time block after physical restraint (protocol hours 2-6), the amount of time spent awake increased and REMS was reduced; SWS was not statistically altered (Fig. 1 ). This restraint-induced increase in the amount of time spent awake was blocked by astressin, whereas the restraint-induced REMS suppression was not ( Fig. 1 ). During postmanipulation hours 7-12, sleep-wake behavior was not statistically Fig. 1 . Restraint-induced alterations in sleep-wake activity after intracerebroventricular (ICV) administration of the corticotropin-releasing hormone receptor antagonist astressin. Rats were injected ICV with either vehicle or 2.5 g (0.7 nmol) astressin and then restrained for 1 h beginning at light (n ϭ 8) or dark onset (n ϭ 8). During the light period, waking was increased and rapid eye movement sleep (REMS) decreased after the restraint period. Restraint-induced increases in waking were blocked by astressin, whereas REMS suppression was not. Restraint at the beginning of the dark period had little effect on subsequent behavior. Values are means Ϯ SE. SWS, slowwave sleep. Open bars, animals during undisturbed baseline recordings (values were matched to time of day for values obtained after restraint); filled bars, same animals receiving restraint ϩ ICV administration of vehicle (pyrogen-free saline); hatched bars, same animals receiving restraint ϩ ICV astressin. * PՅ 0.05 vs. undisturbed baseline; # PՅ 0.05 vs. restraint ϩ vehicle. altered, although there was a tendency for increased REMS when the rats were injected with vehicle before physical restraint ( Fig. 1) .
Analyses of sleep-wake architecture parameters were restricted to time blocks after the physical restraint ended. During postmanipulation hours 2-6 under control conditions (ICV vehicle with restraint), the duration and number of SWS bouts were not altered relative to the values obtained from baseline ( Table 1) . The increased waking observed under control conditions after 1-h restraint was due to an increase in wakefulness bout duration, not bout numbers, whereas the reduction in REMS during this postmanipulation period was due to a reduction in both the number and duration of REMS bouts (Table 1) . Treatment with 2.5 g (0.7 nmol) astressin before restraint resulted in a modest increase in SWS bout duration without altering restraint-induced reductions in REMS bout numbers or duration (Table 1 ).
In addition to alterations in sleep quantity and architecture, EEG SWA during SWS was significantly increased during both time blocks after physical restraint (Fig. 2) . This restraint-induced increase in EEG SWA during SWS was not altered by astressin (Fig. 2) .
Tbr increased during the 1-h restraint period and remained elevated during postmanipulation hours 2-6 ( Fig. 2) . Astressin attenuated but did not completely abolish this restraint-induced increase in Tbr (Fig. 2) .
Effects of restraint during the dark period. One hour of physical restraint at the beginning of the dark period did not alter subsequent sleep-wake behavior, although REMS was reduced during the restraint period (Fig. 1) .
Analyses of sleep-wake architecture parameters indicated that the number of wakefulness bouts was modestly increased during the first 5-h postmanipulation time block, although the bout duration and the Fig. 2 . Effects of ICV administration of astressin on restraint-induced increases in brain temperature (Tbr) and slow-wave activity (SWA) during SWS when rats were restrained for 1 h at the beginning of the light period. Tbr and SWA during SWS were increased by this manipulation. The restraint-induced increase in Tbr was attenuated by astressin, whereas the increase in SWA during SWS was not. Values are means Ϯ SE from 8 rats. Open bars, animals during undisturbed baseline recordings; filled bars, same animals injected ICV with vehicle (pyrogen-free saline) before the restraint period; hatched bars, same animals given 2.5 g astressin (0.7 nmol) ICV before the 1-h restraint period. * PՅ 0.05 vs. undisturbed baseline; # PՅ 0.05 vs. restraint ϩ vehicle. Values are means Ϯ SE. Transitions indicate changes from one behavioral state to another. Hours 2-6 and 7-12 represent time blocks after the restraint period. L-D cycle, period of the light-dark cycle during which restraint and injections took place; (D, dark period; L, light period); Wake, wakefulness; SWS, slow-wave sleep; REMS, rapid eye movement sleep; R ϩ V, restraint ϩ vehicle (pyrogen-free saline); R ϩ A, restraint ϩ astressin. Differences were detected by 1-way ANOVA within the indicated time blocks. *P Յ 0.05, statistically significant difference between values obtained during the undisturbed condition and after 1 h of restraint when animals were pretreated with vehicle; †P Յ 0.05, statistically significant difference between values obtained after restraint ϩ vehicle and after restraint ϩ astressin. time spent awake were not altered. In addition, transitions from one vigilance state to another were increased after 1-h restraint, indicating that the sleep that did occur was fragmented (Table 1) . Astressin did not alter the restraint-induced changes in sleep architecture parameters. EEG SWA during SWS was not altered by 1-h restraint during the dark period (data not shown). Tbr was increased in response to physical restraint, and this increase in Tbr was not altered by astressin (data not shown).
Experiment 2
Effects of restraint on circulating corticosterone concentrations. In naive unoperated rats that were not handled or disturbed before restraint, corticosterone concentrations increased regardless of the timing of the manipulation (Fig. 3) . Corticosterone concentrations of naive rats returned to basal concentrations 1 h after restraint ended (time 2, Fig. 3 ). Corticosterone concentrations of habituated rats injected with vehicle 15 min before light onset and then killed at light onset (time 0, Fig. 3 ) were greater than those of naive rats killed at the same time. The differences in corticosterone between these groups of rats at this time stem from the handling of the injected rats. However, the tendency for increased corticosterone after 1-h restraint during the light period in habituated animals injected with vehicle did not achieve statistical significance. Corticosterone concentrations did not differ between naive and habituated animals when the manipulations were done at dark onset. ICV administration of 2.5 g astressin did not alter circulating corticosterone concentrations after restraint during either the light or the dark period ( Fig. 3) .
DISCUSSION
There is now an abundance of evidence (1, 4, 5, 11, 13, 16, 26) that CRH mediates endocrine, autonomic, immune, and behavioral responses to acute and chronic stressors. Sleep is altered in response to stressors of many modalities (31) . Chronic stress significantly decreases the amount of SWS and REMS and the length of individual SWS and REMS sleep episodes and alters the circadian patterning of sleep (18) . Some acute stressors, such as physical restraint, are reported to primarily induce a REMS rebound (21, 31, 32) . Rampin et al. (32) first reported that a 2-h period of physical restraint applied to rats at the beginning of the dark period induces a significant increase in REMS during the remaining 10 h of the dark period, without altering SWS. Subsequent reports from the same laboratory (10) indicate that ICV administration of the CRH receptor antagonist ␣-hCRH reduces the increase in REMS that follows restraint at the beginning of the dark period, indicating that endogenous CRH may be involved in these responses.
In some respects, the results of the current study contrast with previous findings by del C. Gonzalez and Valatx (10) and Rampin et al. (32) . In the present study, 1-h restraint at the beginning of the dark period (active period) did not alter subsequent SWS, wakefulness, or REMS, whereas the same manipulation during the light period increased wakefulness and reduced REMS for 5 h postmanipulation. To allow recordings of the EEG and other parameters to be obtained during the physical restraint period, the rats were restrained in their home recording cages. Under these conditions, the rats slept while in the restrainer tubes, albeit less than normal. One potential explanation for differences Rats handled and injected ICV with vehicle 15 min before the beginning of the light period and then killed at light onset had significantly greater concentrations of corticosterone than did naive rats killed at t ϭ 0 (#PՅ 0.05 vs. naive rats at t ϭ 0). This increase in corticosterone was due to the interval between handling and death (see Experimental Protocol). Circulating corticosterone concentrations were not statistically altered by 1 h of restraint in habituated rats injected ICV with vehicle or astressin.
with respect to the impact of restraint on REMS observed in our present study and those of the aforementioned reports may be the methods and/or location in which the animals were physically restrained. Novelty is a critical feature of constructs that describe the continuum of responses to stressors. The continuum of responses to stressors ranges from arousal to pathology, depending on the magnitude and duration of the stressor (e.g., see Ref. 19) . There are numerous studies (17, 22) indicating that novel environments, for example, exposure to an open field or elevated-plus maze, constitute stressors for rodents and that the CRH system is involved in mediating responses to these stressors. There is no information provided in the previous studies to which we refer concerning the environment in which the manipulations occurred. For example, if rats are placed in restrainer tubes outside their home recording cages in the general laboratory environment, the stressor would include a component in addition to physical restraint, i.e., being in a novel environment. We did not intend at the outset of this study to develop a stressor that was of greater or lesser magnitude than those previously used. We restrained the animals in their home recording cages to allow an assessment of responses during application of the stressor itself. As such, we believe it likely that our methodology resulted in a stressor of less magnitude than if the manipulation been performed in an environment outside the home recording cage. The impact on subsequent sleepwake behavior was as such reduced.
The fact that many procedures used as stressors also result in sleep deprivation is often thought problematic for interpretation of results from such studies (but see, for example, Ref. 2). Although beyond the scope of this discussion, one philosophic response to such suggestions is that no attempts should be made to separate the impact of acute stressors from that of loss of sleep per se, insofar as sleep-wake behavior may be viewed as a reflection of the status of the whole animal. Nevertheless, under the conditions of the present study, EEG SWA during SWS increased for the duration of the recording period after restraint when the manipulation occurred at the beginning of the light period. EEG SWA during SWS is thought to reflect both sleep debt and intensity (3) and is a characteristic homeostatic response to sleep deprivation. As such, the increase in SWA during SWS that we observed could conceivably be a response to sleep loss per se, rather than to physical restraint. Our findings that EEG SWA increases after restraint at the beginning of the light period are in agreement with previous observations by Meerlo and colleagues (21) of mice manipulated during the middle of the light period. However, we do not feel that the increase in SWA during subsequent SWS observed in our present study is due to sleep loss. Relative to the amount of SWS the rats obtained during the first hour of the light period when undisturbed in their home cages, SWS loss during the restraint period only amounted to 27 min on average. We are not aware of sleep deprivation studies in which rats were deprived of so little sleep, but it is not likely that the increase in SWA during SWS observed after restraint in this study is due to a 27-min sleep loss. For example, Tobler and Borbély (35) demonstrate that 3 h (180 min) of total sleep deprivation of rats by gentle handling at the beginning of the light period does not alter SWA during subsequent SWS and has little impact on the amount of time spent in vigilance states. Furthermore, 1-h physical restraint of BALB/cJ mice during the middle of the light period increases SWA during subsequent SWS by an amount greater than that observed after 1-h sleep deprivation by gentle handling (21) . For these reasons, we believe the increase in SWA during SWS after physical restraint observed in this study is a response to the acute stressor rather than loss of sleep per se. Astressin does not affect the increases of EEG SWA during SWS, although it reduces restraint-induced increases in waking. These observations suggest that increased SWA during SWS is not mediated by the central CRH system, although additional studies are necessary to elucidate the precise mechanisms responsible for these effects.
We (7, 8) have previously targeted the CRH system of well-habituated rats in their home recording cages. Two consistent finding emerge from these studies (7, 8) . First, under the conditions of our studies (7, 8) , antagonizing the CRH system in the absence of overt stressors selectively alters waking and SWS, not REMS. Similar results are obtained when using antisense knockdown strategies to modulate CRH peptide expression; waking is reduced and SWS is increased (unpublished observations). The fact that none of the strategies we have employed to target the CRH system in spontaneously behaving rats alters REMS suggests to us that the CRH system plays little, if any, role in the regulation of this arousal state. As such, our interpretation of data from previous studies (6, 10, 32) reporting an increase in REMS after acute periods of physical restraint is that these responses are likely mediated by other systems. There are several candidate neuropeptides that could mediate the effects of acute physical restraint on subsequent REMS. One of these candidate neuropeptides is prolactin (PRL). PRL is well documented for its ability to enhance REMS (24, 25, 34) . PRL is elevated in response to stressors, including restraint (21) , and has been implicated in ether vapor stress-induced increases in REMS (2) . Because acute periods of physical restraint increase PRL (21) and PRL enhances REMS (24, 25, 34) , restraint-induced increases in REMS may in fact be mediated by this peptide. In addition, CRH induces PRL secretion (23) . Collectively, the findings that PRL secretion is induced by CRH, CRH and PRL are elevated by physical restraint, and PRL enhances REMS suggest that the findings of del C. Gonzalez and Valatx (10) may be attributed to PRL rather than CRH directly. As such, pretreatment with the CRH receptor antagonist ␣-hCRH may block restraint-induced increases in REMS (10), because CRH receptor blockade reduces the impact of CRH on PRL release.
The second finding from our previous studies (7, 8) that is relevant to this discussion is that blockade of CRH receptors of well-habituated, nonstressed rats with appropriate doses of selective CRH receptor antagonists alters sleep-wake behavior only if injections are given before the dark (active) period of the lightdark cycle. Under the conditions of the current study, 1 h of restraint affects subsequent waking and sleep only when the manipulation occurs at the beginning of the light period of the light-dark cycle. The differences in responses to restraint depending on timing of the manipulation may be due to the circadian rhythmicity of the CRH and/or other neurotransmitter/neuropeptide systems. During the dark period, the activity of the CRH system of entrained rats is at its highest (see e.g., Ref. 14) ; any additional modulation by an acute stressor may result in only a minimal increase in CRH activity with little subsequent influence on waking. Conversely, an acute period of restraint during the light period is expected to increase CRH activity to a greater extent, since the activity of the system is at its lowest during this time. Increasing CRH, a potent inducer of waking, at a time when it would normally be low would be expected to increase waking and reduce sleep. This point is illustrated by the responses of rats to ICV administration of CRH; the proportional increase in waking after low doses of CRH is greater when injections are given before light onset than before dark onset (7) . Although circulating corticosterone concentrations, reflective of CRH activity, increase in naive animals regardless of the timing of restraint, the proportional increase is greater when restraint occurs before the light period. These restraint-induced increases in corticosterone of naive, unhabituated rats suggest that the alteration of sleep-wake behavior in response to this manipulation may be due to increased central CRH activity and/or HPA axis activity. However, rats habituated to handling and injection procedures do not exhibit as large a change in corticosterone after restraint as naive rats, and blockade of CRH receptors by ICV administration of astressin into habituated rats reduces restraint-induced increases in waking without altering circulating corticosterone concentrations. The finding that under the conditions of this study ICV administration of the CRH receptor antagonist astressin blocks restraint-induced increases in waking, but not circulating, corticosterone suggests that alterations in waking and sleep by this acute stressor are not greatly modulated by the HPA axis. As such, these responses are likely mediated by other neuropeptide systems, such as PRL as previously mentioned, or central mechanisms, such as CRH actions on the locus ceruleus, which has been implicated in restraint-induced increases in REMS (9) . Additional experiments are necessary to determine if there are differences in restraint-induced increases in PRL depending on the timing of the manipulation, and whether or not the differential responsiveness of CRH and the HPA axis to this manipulation affects PRL secretion.
In conclusion, our results indicate that under the conditions of the current study exposure of rats to physical restraint for 1 h at the beginning of the light period, but not the dark period, increases waking and EEG SWA during SWS and reduces REMS. Blockade of central CRH receptors abolishes restraint-induced alterations in waking, but not REMS, a finding consistent with our previous observations that antagonizing CRH in nonstressed rats does not alter REMS. Collectively, the data derived from this study implicate CRH in some, but not all, responses to this acute manipulation.
Perspectives
The concept of stress and responses to stressors has proven difficult to precisely define; there is often disagreement as to what does or does not constitute a stressor and how the magnitude of a stressor may best be determined. One aspect of research on responses to stressors that is generally agreed on is that stressorinduced increases in HPA axis activity reflect the magnitude of the stressor, as perceived by the animal. Although autonomic markers may be used to define responses to stressors, it is ACTH and glucocorticoids that are most frequently referred to as "stress hormones." If the impact of stressors on behavior is the focus of study, there are multiple levels at which outcome measures may be obtained. The selection of readout parameters other than ACTH and/or glucocorticoids does not invalidate the use of the HPA axis as a measure of responses to stressors, nor does the use of other outcome measures redefine the concept of stress. The results presented in this study illustrate some aspects of this approach. Our finding that rats sleep when placed for the first time in a restrainer tube in their home recording cage suggests to us that under these conditions this manipulation is not perceived by the rat as overly stressful. It is difficult to conceptualize how a healthy animal that is not subjected to a drug would sleep during an event perceived as stressful. Therefore, we believe the extent to which sleep and other complex behavior are altered during or after manipulations thought by the investigator to be stressful reliably serves as a readout of the perception of the animal to that manipulation.
